Q1 2025 Earnings Call Transcript May 15, 2025 Operator: Thank you for standing by. And welcome to Invivyd’s First Quarter 2025 Earnings Conference Call. At this time, all participants are in a ...

"Year to date" sales for 2021, 2022, 2023, and 2024 sales are shown in series at the top of the table and then just below a comparison of 2024 versus 2023 and 2024 versus 2022 is displayed.

"Year to date" sales for 2021, 2022, 2023, and 2024 sales are shown in series at the top of the table and then just below a comparison of 2024 versus 2023 and 2024 versus 2022 is displayed.

announced further progress on Thursday in its Phase 1a clinical trial of TTX-MC138 in patients with metastatic cancer. To date, 13 patients have received at least one dose of TTX-MC138 at four ...

announced the successful completion of the dose escalation (Phase 1) part of its Phase 1/2 clinical trial for CNT201, its recombinant collagenase therapeutic for Dupuytren's contracture.

Despite promising adherence and persistence data, tirzepatide dose escalation was slower in the real-world than clinical trials in patients with obesity without T2D. Tirzepatide dose escalation is ...

We performed a prospective, randomized, double-blind comparison of rofecoxib and naproxen ... 29 Analyses of 7535 patients in double-blind trials comparing rofecoxib with placebo and other NSAIDs ...

Next Steps: - Complete data analysis - Submit to FDA/CDSCO for additional pivotal trials "Dose optimization is a critical milestone for our broad-spectrum antiviral platform," said David Platt ...

Readers are advised to check the appropriate medical literature and the product information currently provided by the manufacturer of each drug to be administered to verify approved uses, the dosage, ...

"The consistency of our results, including 100% viral clearance in prior studies, gives us strong confidence as we prepare for additional clinical trials.” "Dose optimization is a critical ...

Big Tech players will collectively spend over $300 billion on AI-focused infrastructure this year to support the growing ...